Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French Society of Pediatric Oncology

To assess the relevance of MYCN amplification and bone lesions in stage 4 neuroblastoma (NB) in infants aged <1 year, 51 infants with stage 4 NB were enrolled. Three groups of patients were defined according to the type of metastases and the resectability of the primary tumour. Group I comprised...

Descripción completa

Detalles Bibliográficos
Autores principales: Minard, V, Hartmann, O, Peyroulet, M C, Michon, J, Coze, C, Defachelle, A S, Lejars, O, Perel, Y, Bergeron, C, Boutard, P, Leverger, G, Stephan, J L, Thyss, A, Chastagner, P, Couillault, G, Devalck, C, Lutz, P, Mechinaud, F, Millot, F, Plantaz, D, Rialland, X, Rubie, H
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363565/
https://www.ncbi.nlm.nih.gov/pubmed/10993641
http://dx.doi.org/10.1054/bjoc.2000.1412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363565/
https://www.ncbi.nlm.nih.gov/pubmed/10993641
http://dx.doi.org/10.1054/bjoc.2000.1412

Ejemplares similares